Linking type 1 diabetes to bacterial gut populations
====================================================

The incidence of type 1 diabetes (T1D) began to notably rise in the latter half of the last century, and a similar trend was observed for several other autoimmune diseases and conditions. Most cases of T1D are not solely attributable to genetics and therefore, environmental influences are proposed to account for the difference. Humans live today in general under much more hygienic conditions than their ancestors. Viral infections, in particular human enterovirus (HEV) infections, currently reperesent the most likely environmental cause of T1D. In addition, bacteria are increasingly seen as players in T1D etiology. A recent review by Dr Nora Chapman and colleagues discusses the gut biome as another factor linking changes in human hygiene to T1D infection. Recent work shows that the bacterial genera in the gut of diabetics compared with non-diabetics, can vary significantly. The authors consider these data in light of the non-hygienic human past in order to discuss a possible relationship between the resident bacterial biome and acute infectious events by HEV, suggesting how this may have influenced T1D incidences in the past and the risk for developing T1D today.
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Bacteriophage cocktail reduces *Escherichia coli* O157:H7 contamination of foods
================================================================================

*Escherichia coli* O157:H7 is a Shiga toxin producing member of enterohemorrhagic *E. coli* (STEC). It is one of the major foodborne bacterial pathogens with significant importance to public health and economics. Efforts to reduce contamination with *E. coli* O157:H7 have largely focused on washing, application of various antibacterial chemicals, and gamma-irradiation, each of which has practical and environmental drawbacks. The use of lytic bacteriophages as biocontrol agents is a relatively recent, environmentally-friendly approach proposed for eliminating or significantly reducing bacterial contamination of foods. A variety of phage-based preparations have been recently approved for direct food applications in the US and Europe; i.e., ListShield, Listex P-100 and EcoShield. A recent study set out to determine whether treatment with EcoShield, a bacteriophage cocktail composed of three *E. coli* O157:H7-specific lytic bacteriophages, can safely and significantly reduce *E. coli* O157:H7 levels in lettuce and beef under conditions that mimic their normal storage conditions, and prevent phage-treated foods from being recontaminated with the bacteria. Dr Chandi Carter and colleagues found that EcoShield significantly reduced the levels of the *E. coli* O157:H7 in experimentally contaminated beef by 94% and in lettuce by 87% after a five minute contact time. The reduced levels of bacteria were maintained for at least one week at refrigerated temperatures. However, the one-time application of EcoShield did not protect the foods from recontamination with *E. coli* O157:H7. The study results demonstrate that EcoShield is effective in significantly reducing contamination of beef and lettuce with *E. coli* O157:H7, but does not protect against potential later contamination due to, for example, unsanitary handling of the foods post processing.
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Mathematical modeling: efficacy of universal rotavirus vaccination
==================================================================

Group A rotavirus (RV-A) is the leading cause of severe diarrheal disease in infants and young children worldwide. Currently, there are two licensed vaccines against rotavirus infection; Rotateq by Merck and Rotarix by GlaxoSmithKline. In Malaysia, both vaccines have been available since 2006, but they are not part of the national immunization program, and coverage remains low at about 5%. A new study by Dr Way Seah Lee and colleagues looked at RV-A genotypes isolated in Malaysia to estimate the effectiveness of nationwide RV-A vaccination in Malaysia. A simple mathematical model was used, with input from a two-year, two-center, prospective study on hospitalization of RV-A gastroenteritis (RVGE) in young children, published data on RV-A hospitalizations and genotypes, mortality on childhood GE and published genotype-specific efficacy data on two RV-A vaccines. Assuming a 95% vaccine coverage, the overall projected effectiveness was up to 88% for Rotateq and up to over 90% for Rotarix against RVGE-related hospitalizations. The projected annual reduction in RVGE-related deaths was 27 to 32 deaths (from 34 deaths) for Rotateq and 28 to 32 deaths annually forRotarix. The authors conclude that comprehensive RV-A vaccination is efficacious in reducing RVGE-related hospitalizations and mortality in Malaysia. The study makes a strong case for introducing universal RV-A vaccination in Malaysia and other countries.
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Interactions of *Salmonella enterica* with dendritic cells
==========================================================

Dendritic cells (DCs) form an important link between innate and adaptive immunity. However, DCs are also deployed as vehicles for systemic spread of pathogens. Salmonella is an important gastrointestinal pathogen causing diseases ranging from gastroenteritis to typhoid fever. DCs play an important role in the immunity against Salmonella infection, but this pathogen has also evolved efficient mechanisms to persist after phagocytosis by DCs, to spread using DCs as vehicles, and to interfere with the central function of DCs, the processing of antigens and presentation of antigen-derived peptides to T cells for the stimulation of adaptive immune responses. A recent review by Drs Swart and Hensel focuses on the interface between Salmonella and DCs. The routes used by Salmonella to breach intestinal barriers, the intracellular habitat of Salmonella in DCs, intracellular activities, as well as manipulation and evasion of DC-mediated immune responses are discussed.
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